Undertreatment or Overtreatment With Statins: Where Are We?

Undertreatment or Overtreatment With Statins: Where Are We?

Statins, in addition to healthy lifestyle interventions, are the cornerstone of lipid-lowering therapy. Other low-density lipoprotein (LDL)-lowering drugs include ezetimibe, bile acid sequestrants, and PCSK9 inhibitors. As new evidence emerges from new clinical trials, therapeutic goals change, lead...

Full description

Bibliographic Details
Main Authors: Irene García-Fernández-Bravo, Ana Torres-Do-Rego, Antonio López-Farré, Francisco Galeano-Valle, Pablo Demelo-Rodriguez, Luis A. Alvarez-Sala-Walther
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
statins
cardiovascular risk
HDL-cholesterol
LDL-cholesterol
PCSK9 inhibitor
primary prevention
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.808712/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.808712/full

Similar Items